Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells | Zendy

Yuhko Suzuki | Zendy; Tsutomu Yoshida | Zendy; Guoqin Wang | Zendy; Takumi Aoki | Zendy; Takuji Katayama | Zendy; Shunsuke Miyamoto | Zendy; Kôji Miyazaki | Zendy; Keiichi Iwabuchi | Zendy; Mikio Danbara | Zendy; Meijin Nakayama | Zendy; Ryouichi Horie | Zendy; Hirokazu Nakamine | Zendy; Yuichi Sato | Zendy; Naoya Nakamura | Zendy; Nozomi Niitsu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells

Author(s) -

Yuhko Suzuki,

Tsutomu Yoshida,

Guoqin Wang,

Takumi Aoki,

Takuji Katayama,

Shunsuke Miyamoto,

Kôji Miyazaki,

Keiichi Iwabuchi,

Mikio Danbara,

Meijin Nakayama,

Ryouichi Horie,

Hirokazu Nakamine,

Yuichi Sato,

Naoya Nakamura,

Nozomi Niitsu

Publication year - 2013

Publication title -

acta haematologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.574

H-Index - 56

eISSN - 1421-9662

pISSN - 0001-5792

DOI - 10.1159/000348550

Subject(s) - lymphoma , immunohistochemistry , diffuse large b cell lymphoma , pathology , incidence (geometry) , cd8 , flow cytometry , medicine , pathogenesis , clinical significance , biology , immunology , immune system , physics , optics

Aberrant expression of T-cell markers is occasionally observed in B-cell lymphomas. We conducted a retrospective study to establish its incidence and to determine its relationship with clinical features of patients with diffuse large B-cell lymphoma (DLBCL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research